CIPC

gene
On this page

Summary

CIPC (CLOCK interacting pacemaker, HGNC:20365) is a protein-coding gene on chromosome 14q24.3, encoding CLOCK-interacting pacemaker (Q9C0C6). Transcriptional repressor which may act as a negative-feedback regulator of CLOCK-BMAL1 transcriptional activity in the circadian-clock mechanism.

Predicted to be involved in negative regulation of DNA-templated transcription and negative regulation of circadian rhythm. Located in cytosol; nucleolus; and nucleoplasm.

Source: NCBI Gene 85457 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 61 total
  • MANE Select transcript: NM_033426

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20365
Approved symbolCIPC
NameCLOCK interacting pacemaker
Location14q24.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000198894
Ensembl biotypeprotein_coding
OMIM616995
Entrez85457

Gene structure

Transcript identifiers

Ensembl transcripts: 22 — 21 protein_coding, 1 retained_intron

ENST00000361786, ENST00000554447, ENST00000554658, ENST00000555200, ENST00000555437, ENST00000555611, ENST00000556863, ENST00000557115, ENST00000880022, ENST00000880023, ENST00000880024, ENST00000880025, ENST00000880026, ENST00000880027, ENST00000880028, ENST00000880029, ENST00000930386, ENST00000930387, ENST00000971302, ENST00000971303, ENST00000971304, ENST00000971305

RefSeq mRNA: 1 — MANE Select: NM_033426 NM_033426

CCDS: CCDS9855

Canonical transcript exons

ENST00000361786 — 4 exons

ExonStartEnd
ENSE000009119777710981277109981
ENSE000009410657711342577117287
ENSE000012403077709825877098361
ENSE000035292567710565777105844

Expression profiles

Bgee: expression breadth ubiquitous, 254 present calls, max score 97.84.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 17.0827 / max 215.5820, expressed in 1795 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
14075616.90881794
1407570.173970

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
skeletal muscle tissue of rectus abdominisUBERON:000451197.84gold quality
quadriceps femorisUBERON:000137797.73gold quality
vastus lateralisUBERON:000137997.69gold quality
tibialis anteriorUBERON:000138597.33gold quality
deltoidUBERON:000147697.25gold quality
skeletal muscle tissueUBERON:000113497.19gold quality
left ventricle myocardiumUBERON:000656696.61gold quality
biceps brachiiUBERON:000150796.55gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450296.44gold quality
gastrocnemiusUBERON:000138896.07gold quality
muscle tissueUBERON:000238596.05gold quality
cardiac muscle of right atriumUBERON:000337995.62gold quality
muscle of legUBERON:000138395.54gold quality
hindlimb stylopod muscleUBERON:000425295.36gold quality
upper arm skinUBERON:000426394.82gold quality
bronchial epithelial cellCL:000232894.71gold quality
bronchusUBERON:000218594.09gold quality
lateral globus pallidusUBERON:000247694.00gold quality
corpus callosumUBERON:000233693.84gold quality
globus pallidusUBERON:000187593.78gold quality
inferior vagus X ganglionUBERON:000536393.75gold quality
medial globus pallidusUBERON:000247793.74gold quality
myocardiumUBERON:000234993.48gold quality
lateral nuclear group of thalamusUBERON:000273693.44gold quality
subthalamic nucleusUBERON:000190693.40gold quality
mucosa of paranasal sinusUBERON:000503093.38gold quality
dorsal plus ventral thalamusUBERON:000189793.35gold quality
superior vestibular nucleusUBERON:000722793.34gold quality
cerebellumUBERON:000203793.19gold quality
cerebellar cortexUBERON:000212993.09gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.74

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

171 targeting CIPC, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-4481100.0066.421669
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-186-5P99.9970.833707
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-428299.9975.366408
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-1229-3P99.9766.49906
HSA-MIR-314899.9775.066478
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-3605-5P99.9667.12932
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-570-3P99.9672.414910
HSA-MIR-302E99.9670.742669
HSA-MIR-365899.9673.874379
HSA-MIR-590-3P99.9674.346478

Literature-anchored findings (GeneRIF, showing 1)

  • Since CAD and Erk have significant roles in cell proliferation and cell cycle, CIPC may work as a cell cycle regulator by interacting with these binding proteins. (PMID:26657846)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriocipcaENSDARG00000075397
danio_reriocipcbENSDARG00000078095
mus_musculusCipcENSMUSG00000034157
rattus_norvegicusCipcENSRNOG00000011111

Protein

Protein identifiers

CLOCK-interacting pacemakerQ9C0C6 (reviewed: Q9C0C6)

Alternative names: CLOCK-interacting circadian protein

All UniProt accessions (7): Q9C0C6, G3V310, G3V3Y7, G3V405, G3V4V0, G3V5J4, G3V5Y7

UniProt curated annotations — full annotation on UniProt →

Function. Transcriptional repressor which may act as a negative-feedback regulator of CLOCK-BMAL1 transcriptional activity in the circadian-clock mechanism. May stimulate BMAL1-dependent phosphorylation of CLOCK. However, the physiological relevance of these observations is unsure, since experiments in an animal model showed that CIPC is not critially required for basic circadian clock.

Subunit / interactions. Interacts with CLOCK. Forms a ternary complex with the CLOCK-BMAL1 heterodimer. Interacts with CAD and HSPA5.

Subcellular location. Nucleus. Cytoplasm. Cytosol.

RefSeq proteins (1): NP_219494* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR031602CIPCFamily

Pfam: PF15800

UniProt features (13 total): region of interest 3, sequence variant 2, mutagenesis site 2, compositionally biased region 2, chain 1, coiled-coil region 1, short sequence motif 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9C0C6-F158.880.16

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 213

Mutagenesis-validated functional residues (2):

PositionPhenotype
186loss of predominant localization in the nucleus; when associated with a-187. no effect on cad- and hspa5-binding; when a
187loss of predominant localization in the nucleus; when associated with a-186. no effect on cad- and hspa5-binding; when a

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-9931510Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes

MSigDB gene sets: 205 (showing top): GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP, GOBP_CIRCADIAN_RHYTHM, RNGTGGGC_UNKNOWN, GCM_PTPRD, GOLDRATH_IMMUNE_MEMORY, TGACCTY_ERR1_Q2, SRF_Q5_01, GOBP_REGULATION_OF_CIRCADIAN_RHYTHM, chr14q24, NF1_Q6_01, WCTCNATGGY_UNKNOWN, USF_01, GGCKCATGS_UNKNOWN, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN

GO Biological Process (3): negative regulation of circadian rhythm (GO:0042754), negative regulation of DNA-templated transcription (GO:0045892), rhythmic process (GO:0048511)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (5): nucleus (GO:0005634), nucleoplasm (GO:0005654), nucleolus (GO:0005730), cytosol (GO:0005829), cytoplasm (GO:0005737)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Circadian clock1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
nuclear lumen2
circadian rhythm1
regulation of circadian rhythm1
negative regulation of biological process1
DNA-templated transcription1
regulation of DNA-templated transcription1
negative regulation of RNA biosynthetic process1
biological_process1
binding1
intracellular membrane-bounded organelle1
intracellular membraneless organelle1
cytoplasm1
intracellular anatomical structure1

Protein interactions and networks

STRING

420 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CIPCCIARTQ8N365530
CIPCNR1D2Q14995505
CIPCITGB1BP1O14713439
CIPCBMAL2Q8WYA1432
CIPCPER3P56645411
CIPCBMAL1O00327380
CIPCMSRAQ9UJ68373
CIPCPER2O15055370
CIPCLIPCP11150370
CIPCE2F6O75461347
CIPCNPAS2Q99743345
CIPCCEBPDP49716344
CIPCRUNDC1Q96C34319
CIPCRPS19P39019316
CIPCCLOCKO15516307

IntAct

17 interactions, top by confidence:

ABTypeScore
COPS5COPS2psi-mi:“MI:0914”(association)0.910
BMAL2CLOCKpsi-mi:“MI:0914”(association)0.670
CIPCRABGEF1psi-mi:“MI:0915”(physical association)0.560
NCK2CIPCpsi-mi:“MI:0915”(physical association)0.560
CIPCCLOCKpsi-mi:“MI:0914”(association)0.530
COPS5FBLL1psi-mi:“MI:0914”(association)0.350
COPS5COPS2psi-mi:“MI:0914”(association)0.350
NPAS2FHL2psi-mi:“MI:0914”(association)0.350
CIPCBMAL1psi-mi:“MI:0914”(association)0.350
NCK2CIPCpsi-mi:“MI:0915”(physical association)0.000
VPS26CCIPCpsi-mi:“MI:0915”(physical association)0.000
APPL1CIPCpsi-mi:“MI:0915”(physical association)0.000

BioGRID (27): CIPC (Two-hybrid), CIPC (Affinity Capture-RNA), CIPC (Affinity Capture-RNA), CLOCK (Two-hybrid), CSNK2B (Two-hybrid), DEC1 (Two-hybrid), RORC (Two-hybrid), CIPC (Affinity Capture-MS), ZMYM4 (Affinity Capture-MS), CLOCK (Affinity Capture-MS), CIPC (Affinity Capture-MS), CLOCK (Affinity Capture-MS), CIPC (Affinity Capture-MS), ZMYM4 (Affinity Capture-MS), CIPC (Two-hybrid)

ESM2 similar proteins: A0P8Z5, B0KYV5, B1WC58, B2RYR0, F1LR10, F6SNN2, O75128, O75410, P51826, P61590, P61591, P61592, P61593, P61594, Q3USH1, Q501R9, Q5IFK1, Q5PQK4, Q5R8C5, Q5SU73, Q5SWA1, Q5U5Q9, Q6NZF1, Q6P1D7, Q6P7W0, Q6PJW8, Q6Y685, Q6ZSG2, Q6ZVT6, Q7TT79, Q80XI1, Q80XJ2, Q80YR6, Q86T90, Q8BFU3, Q8C9B9, Q8IY92, Q8IYW5, Q8ND24, Q8NEM0

Diamond homologs: Q5R8C5, Q6NRH7, Q8R0W1, Q9C0C6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

61 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance59
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

709 predictions. Top by Δscore:

VariantEffectΔscore
14:77105656:GGGCA:Gacceptor_gain1.0000
14:77105829:G:GTdonor_gain1.0000
14:77098355:GCCC:Gdonor_gain0.9900
14:77105653:ATAG:Aacceptor_gain0.9900
14:77105815:C:Gdonor_gain0.9900
14:77105842:CAG:Cdonor_loss0.9900
14:77105843:AG:Adonor_loss0.9900
14:77105844:G:GCdonor_loss0.9900
14:77105844:GG:Gdonor_loss0.9900
14:77105845:GTT:Gdonor_loss0.9900
14:77098360:AGGTG:Adonor_loss0.9800
14:77098361:GGTGA:Gdonor_loss0.9800
14:77098362:GTG:Gdonor_loss0.9800
14:77098363:T:Adonor_loss0.9800
14:77098363:T:Gdonor_loss0.9800
14:77098371:G:GTdonor_gain0.9800
14:77098372:G:Tdonor_gain0.9800
14:77105652:CATA:Cacceptor_loss0.9800
14:77105654:T:Gacceptor_gain0.9800
14:77105655:A:ACacceptor_loss0.9800
14:77105655:A:AGacceptor_gain0.9800
14:77105656:G:GGacceptor_gain0.9800
14:77105846:T:Gdonor_gain0.9800
14:77106245:ATACT:Adonor_gain0.9800
14:77105655:AG:Aacceptor_gain0.9600
14:77105656:GG:Gacceptor_gain0.9600
14:77105760:G:GGdonor_gain0.9600
14:77109806:CACCA:Cacceptor_loss0.9600
14:77109807:ACCAG:Aacceptor_loss0.9600
14:77109808:CCA:Cacceptor_loss0.9600

AlphaMissense

2595 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:77114089:T:CL324P0.999
14:77114104:T:CL329S0.999
14:77114176:T:CL353P0.999
14:77114068:T:CF317S0.998
14:77114089:T:AL324Q0.998
14:77114097:T:CS327P0.998
14:77114134:T:CL339S0.998
14:77105838:T:CF44L0.997
14:77105840:T:AF44L0.997
14:77105840:T:GF44L0.997
14:77114101:G:TG328V0.997
14:77114205:G:CA363P0.997
14:77114107:T:CL330P0.996
14:77114067:T:CF317L0.995
14:77114069:T:AF317L0.995
14:77114069:T:GF317L0.995
14:77114086:T:AV323D0.995
14:77114113:T:CI332T0.995
14:77114113:T:GI332S0.995
14:77114143:A:CQ342P0.995
14:77114167:T:CL350P0.995
14:77114074:A:TN319I0.994
14:77114080:T:CL321P0.994
14:77114089:T:GL324R0.993
14:77114104:T:GL329W0.992
14:77114242:T:CL375P0.992
14:77113609:C:AA164D0.991
14:77114068:T:GF317C0.991
14:77113585:T:CI156T0.990
14:77114064:C:AR316S0.990

dbSNP variants (sampled 300 via entrez): RS1000989953 (14:77106778 T>C), RS1001085758 (14:77115608 A>G), RS1001107859 (14:77101766 C>T), RS1001449272 (14:77116738 G>A), RS1001482400 (14:77104941 TCA>T), RS1001506814 (14:77102742 C>A,T), RS1001598403 (14:77105252 C>G), RS1002106176 (14:77096313 C>T), RS1002455357 (14:77115245 T>G), RS1002875250 (14:77115651 A>G), RS1002903036 (14:77100457 G>T), RS1003128160 (14:77103930 C>A,T), RS1003274383 (14:77103799 G>A), RS1003340082 (14:77097751 C>A,T), RS1003396959 (14:77104292 G>A)

Disease associations

OMIM: gene MIM:616995 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST008759_16Intake of total sugars4.000000e-06
GCST90011898_25Alanine aminotransferase levels3.000000e-08
GCST90011899_24Aspartate aminotransferase levels3.000000e-09

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0010158sugar consumption measurement
EFO:0004736aspartate aminotransferase measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
Smokeincreases expression, decreases expression, increases abundance2
sodium arsenitedecreases expression1
abrinedecreases expression1
Resveratrolaffects cotreatment, increases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicaffects methylation1
Benzo(a)pyreneincreases expression1
Carbamazepineaffects expression1
Cisplatinincreases expression1
Doxorubicindecreases expression1
Hydrogen Peroxideincreases expression1
Plant Extractsaffects cotreatment, increases expression1
Quercetindecreases expression1
Thiramdecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Urethanedecreases expression1
Valproic Acidaffects expression1
Cyclosporineincreases expression1
Cadmium Chloridedecreases expression1
Copper Sulfatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.